HMGB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.049620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.874780E-01
Normal-vs-Stage2
1.129030E-01
Normal-vs-Stage3
2.278800E-01
Normal-vs-Stage4
5.729400E-01
Stage1-vs-Stage2
9.336000E-01
Stage1-vs-Stage3
5.540800E-01
Stage1-vs-Stage4
5.837000E-01
Stage2-vs-Stage3
3.777800E-01
Stage2-vs-Stage4
5.045200E-01
Stage3-vs-Stage4
4.368200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.181190E-01
Normal-vs-AfricanAmerican
6.435500E-02
Normal-vs-Asian
1.386160E-01
Caucasian-vs-AfricanAmerican
3.039800E-01
Caucasian-vs-Asian
6.706000E-01
AfricanAmerican-vs-Asian
5.233200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.191360E-01
Normal-vs-Female
1.071040E-01
Male-vs-Female
8.915200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.287800E-01
Normal-vs-Age(41-60Yrs)
1.094240E-01
Normal-vs-Age(61-80Yrs)
1.185630E-01
Normal-vs-Age(81-100Yrs)
4.065600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.271000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.415000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.463400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.974400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.865600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.850000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.069040E-01
Normal-vs-Daily Drinker
1.786050E-01
Normal-vs-Weekly Drinker
4.956300E-02
Normal-vs-Occasional Drinker
2.181400E-01
Normal-vs-Social Drinker
4.550200E-02
Non Drinker-vs-Daily Drinker
5.763800E-01
Non Drinker-vs-Weekly Drinker
6.309000E-01
Non Drinker-vs-Occasional Drinker
1.416800E-01
Non Drinker-vs-Social Drinker
9.263600E-01
Daily Drinker-vs-Weekly Drinker
3.391200E-01
Daily Drinker-vs-Occasional Drinker
3.829000E-01
Daily Drinker-vs-Social Drinker
6.532800E-01
Weekly Drinker-vs-Occasional Drinker
4.889900E-02
Weekly Drinker-vs-Social Drinker
5.224800E-01
Occasional Drinker-vs-Social Drinker
1.233630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.152440E-01
Normal-vs-Grade 2
5.644200E-03
Normal-vs-Grade 3
7.997300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.261800E-01
Grade 1-vs-Grade 3
2.741800E-01
Grade 1-vs-Grade 4
1.152440E-01
Grade 2-vs-Grade 3
9.333600E-01
Grade 2-vs-Grade 4
5.644200E-03
Grade 3-vs-Grade 4
7.997300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.957600E-02
Normal-vs-NonDiabetic
9.064000E-02
Diabetic-vs-NonDiabetic
4.955000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.033600E-02
Normal-vs-NoPancreatitis
9.505700E-02
Pancreatitis-vs-NoPancreatitis
7.425600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.104000E-01
Normal-vs-N1
1.208780E-01
N0-vs-N1
7.637400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.384000E-01
Normal-vs-TP53-NonMutant
9.685700E-02
TP53-Mutant-vs-TP53-NonMutant
5.179500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
